“Neurological manifestations of COVID-19” - guideline of the German society of neurology

被引：0

作者：

Peter Berlit

Julian Bösel

Georg Gahn

Stefan Isenmann

Sven G. Meuth

Christian H. Nolte

Marc Pawlitzki

Felix Rosenow

Benedikt Schoser

Götz Thomalla

Thomas Hummel

机构：

[1] Secretary General of the German Society of Neurology,Department of Neurology

[2] Klinikum Kassel,Department of Neurology

[3] DGNI,Department of Neurology and Clinical Neurophysiology

[4] Klinikum Karlsruhe,Department of Neurology

[5] DGNI,Department of Neurology with Institute for Translational Neurology

[6] St. Josef Hospital Moers,Epilepsy Center Frankfurt Rhein

[7] University Hospital Düsseldorf,Main, Center of Neurology and Neurosurgery

[8] Department of Neurology with Experimental Neurology and Center for Stroke Research Berlin (CSB) Charité-University Berlin,Friedrich Baur Institute at the Neurological Department

[9] University Hospital Münster,Department of Neurology, Head and Neurocenter

[10] University Hospital Frankfurt,Interdisciplinary Center for Smelling and Tasting, University ENT Hospital Dresden

[11] LM-University Munich,undefined

[12] University Hospital Hamburg-Eppendorf,undefined

[13] German Society for ENT Medicine,undefined

来源：

Neurological Research and Practice | / 2卷

关键词：

SARS-CoV-2; COVID-19; Anosmia; Hyposmia; Encephalopathy; Encephalitis; Epileptic seizures; Seizure recurrence; Meningoencephalitis; Myelitis; Encephalomyelitis; Neuromuscular diseases; Myositis; Myasthenia gravis; Guillain-Barré syndrome; Miller Fisher syndrome; Critical illness weakness; Critical illness neuropathy/myopathy; Intensive care unit acquired weakness; ECMO; Ventilation; Delirium; Status epilepticus; Stroke; Intracerebral hemorrhage; Intracranial hemorrhage;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Infection with the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) leads to a previously unknown clinical picture, which is known as COVID-19 (COrona VIrus Disease-2019) and was first described in the Hubei region of China. The SARS-CoV-2 pandemic has implications for all areas of medicine. It directly and indirectly affects the care of neurological diseases. SARS-CoV-2 infection may be associated with an increased incidence of neurological manifestations such as encephalopathy and encephalomyelitis, ischemic stroke and intracerebral hemorrhage, anosmia and neuromuscular diseases.

引用

共 254 条

[1]

Chaumont H(2020)Acute meningoencephalitis in a patient with COVID-19 Revue Neurologique (Paris) 176 519-521

[2]

Etienne P(2020)Meningoencephalitis without respiratory failure in a young female patient with COVID-19 infection in downtown Los Angeles, early April 2020 Brain, Behavior, and Immunity 87 33-158

[3]

Roze E(2020)Plasmapheresis treatment in COVID-19-related autoimmune meningoencephalitis: Case series Brain, Behavior, and Immunity 87 155-555

[4]

Couratier C(2020)The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients Journal of Medical Virology 92 552-1654

[5]

Roger PM(2020)Post SARS-CoV-2 Guillain-Barre syndrome Clinical Neurophysiology 131 1652-518

[6]

Lannuzel A(2020)COVID-19 may induce Guillain-Barre syndrome Revue Neurologique (Paris) 176 516-519

[7]

Duong L(2020)Covid-19 and Guillain-Barre syndrome: More than a coincidence! Revue Neurologique (Paris) 176 518-e605

[8]

Xu P(2020)Miller Fisher syndrome and polyneuritis cranialis in COVID-19 Neurology. 95 e601-1879

[9]

Liu A(2020)Guillain-Barre syndrome following COVID-19: New infection, old complication? Journal of Neurology 267 1877-1884

[10]

Dogan L(2020)Acute polyradiculoneuritis with locked-in syndrome in a patient with Covid-19 Journal of Neurology 267 1883-207

← 1 2 3 4 5 6 7 8 9 10 →